via Smithsonian Magazine
For women, mammograms are a sometimes uncomfortable, but necessary, annual ritual. But this procedure doesn’t always provide accurate results, and it exposes women to X-rays. In a study appearing in ACS’ journal MolecularPharmaceutics, scientists report that they have developed a non-invasive “disease screening pill” that can make cancerous tumors light up when exposed to near-infrared light in mice without using radiation.
Breast cancer is the second most common cancer in women, according to the American Cancer Society. Mammograms are X-rays of breast tissue that can provide information about a lump’s location and size, but they can’t distinguish between cancerous and benign growths. As a result, up to one in three healthy women undergo unnecessary breast cancer treatments and procedures, according to a recent study by researchers in Denmark. Mammograms also require low levels of radiation. While risk of harm from this exposure is minimal, repeated X-rays can potentially cause health issues. Fluorescent probes can detect breast tumors, but they must be given intravenously. So, Greg M. Thurber and colleagues set out to develop a more accurate, safer technique that was also non-invasive.
The researchers combined two types of molecules into a single pill: a targeting molecule that binds to proteins on the surface of breast cancer cells; and a dye that had negatively charged sulfate groups attached to it. Sulfate groups enhance the solubility of near-infrared florescent dyes, increasing the likelihood of detecting the tumor. Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background noise. The researchers say that the pill could lead to an accurate, safe and noninvasive way to detect breast cancer, and it could be modified in the future to detect other diseases.
Learn more: Diagnosing breast cancer with an imaging pill
The Latest on: Imaging pill
via Google News
The Latest on: Imaging pill
- Smart Pills Market Research Projection By Technology, Research, Growth, Pharma, Effects, Segments, Demand, Sales, Revenue Analysis Forecast 2026on November 27, 2019 at 4:53 am
The major companies that are involved in Smart Pills are GE Healthcare, Given Imaging, Inc., Cerner Corporation, Proteus Digital Health, Inc., Karl Storz GmbH & Co. KG, Fujifilm Holdings Corporation, ...
- Global Blood secures FDA approval for new pill to treat sickle cell diseaseon November 25, 2019 at 1:16 pm
The Food and Drug Administration on Monday approved a once-daily pill for sickle cell disease that works in an entirely new way ... required to conduct a follow-on clinical trial to confirm the drug’s ...
- AHA: Amarin's Vascepa halts progression of arterial plaque in key studyon November 17, 2019 at 1:32 pm
PHILADELPHIA––One year after a cardiovascular outcomes study for Amarin's Vascepa took the American Heart Association Scientific Sessions by storm, the fish-oil pill is back—and on the verge of ...
- Smart Pills Market Scope: Astonishing Growth,Share, Trends, Growth, Opportunities and Top Key players-Medtronic, Inc., Proteus Digital Healthon November 11, 2019 at 3:44 am
Global smart pills market is anticipated to post a notable CAGR of ... Medimetrics & Bio-Images Research, Given Imaging, Inc. and Philips Healthcare. The profiling enfolds key information of the ...
- Imaging Spectroscopy Sheds New Light on Pill Productionon September 30, 2019 at 5:00 pm
Today, "pills" have evolved into a sophisticated component of the ... Two relatively recent additions to the spectroscopy toolset are hyperspectral imaging, and terahertz imaging and spectroscopy.
- A Single Dose for Good Measure: How an Anti-Nuclear-Contamination Pill Could Also Help MRI Patientson September 12, 2019 at 8:03 am
That’s because the active pharmaceutical ingredient in the pill – what scientists call a “chelator ... a critical ingredient in widely used contrast dyes for MRI (magnetic resonance imaging) scans. “I ...
- Diagnosing breast cancer with an imaging pillon May 16, 2019 at 1:51 am
Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background ...
- Imaging Pill to Diagnose Breast Canceron May 17, 2018 at 7:30 pm
Testing in mice showed that with this formulation, a considerable proportion of the imaging agent was absorbed into the bloodstream. It also bound specifically to cancer cells with little background ...
- Imaging Pill Diagnosing Breast Canceron May 15, 2018 at 5:00 pm
This imaging pill was developed combining two types of molecules: a dye which has negatively charged sulfate groups attached to it; and one targeting a molecules that binds to proteins on the surface ...
via Bing News
